Novo Nordisk stock forecast
Novo Nordisk (NOV) Stock Forecast & Price Target
NOV Analyst Ratings
NOV Stock 12 Month Forecast
Average Price Target
€38.61▲(3.95% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Kerry Holford | Berenberg Bank | €40.80 | hold | 9.86%Upside | Reiterated | 11/13/26 | ||
| Emmanuel Papadakis | Deutsche Bank | €32.11 | sell | -13.56%Downside | Reiterated | 11/11/26 | ||
| Justin Smith | Bernstein | €27.16→€29.83 | sell | -19.68%Downside | Reiterated | 11/06/26 | ||
| James Quigley | Goldman Sachs | €38.79→€40.67 | hold | 9.50%Upside | Reiterated | 11/05/26 | ||
| Matthew Weston | UBS | €44.41→€41.74 | hold | 12.38%Upside | Reiterated | 11/05/26 | ||
| Graham Parry | Citi | €39.60→€39.86 | hold | 7.33%Upside | Reiterated | 11/05/26 | ||
| Michael Leuchten | Jefferies | €36.79 | hold | -0.95%Downside | Reiterated | 11/04/26 | ||
| Richard Vosser | J.P. Morgan | €36.79 | hold | -0.95%Downside | Reiterated | 11/04/26 | ||
| Sachin Jain | Bank of America Securities | €46.82 | hold | 26.06%Upside | Reiterated | 11/04/26 | ||
| Thibault Boutherin | Morgan Stanley | €33.44 | sell | -9.95%Downside | Downgraded | 09/11/26 | ||
| Rajesh Kumar | HSBC | €40.13→€42.81 | hold | 15.26%Upside | Reiterated | 09/10/26 | ||
| James Gordon CFA | Barclays | €41.47→€40.13 | hold | 8.05%Upside | Reiterated | 09/08/26 | ||
| Nico Chen | DBS | €40.13 | hold | 8.05%Upside | Reiterated | 08/25/26 | ||
| Elmar Kraus | DZ BANK AG | ― | hold | ― | Reiterated | 08/07/26 | ||
| Martin Brenoe | Nordea Markets | €46.82 | buy | 26.06%Upside | Upgraded | 06/19/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Kerry HolfordBerenberg Bank | HoldReiterated€40.80 | 11/13/26 | 9.86%Upside | ||
| Emmanuel PapadakisDeutsche Bank | SellReiterated€32.11 | 11/11/26 | -13.56%Downside | ||
| Justin SmithBernstein | SellReiterated€27.16→€29.83 | 11/06/26 | -19.68%Downside | ||
| James QuigleyGoldman Sachs | HoldReiterated€38.79→€40.67 | 11/05/26 | 9.50%Upside | ||
| Matthew WestonUBS | HoldReiterated€44.41→€41.74 | 11/05/26 | 12.38%Upside | ||
| Graham ParryCiti | HoldReiterated€39.60→€39.86 | 11/05/26 | 7.33%Upside | ||
| Michael LeuchtenJefferies | HoldReiterated€36.79 | 11/04/26 | -0.95%Downside | ||
| Richard VosserJ.P. Morgan | HoldReiterated€36.79 | 11/04/26 | -0.95%Downside | ||
| Sachin JainBank of America Securities | HoldReiterated€46.82 | 11/04/26 | 26.06%Upside | ||
| Thibault BoutherinMorgan Stanley | SellDowngraded€33.44 | 09/11/26 | -9.95%Downside | ||
| Rajesh KumarHSBC | HoldReiterated€40.13→€42.81 | 09/10/26 | 15.26%Upside | ||
| James Gordon CFABarclays | HoldReiterated€41.47→€40.13 | 09/08/26 | 8.05%Upside | ||
| Nico ChenDBS | HoldReiterated€40.13 | 08/25/26 | 8.05%Upside | ||
| Elmar KrausDZ BANK AG | HoldReiterated | 08/07/26 | ― | ||
| Martin BrenoeNordea Markets | BuyUpgraded€46.82 | 06/19/26 | 26.06%Upside |
Best Analysts Covering Novo Nordisk
Copying Emmanuel Papadakis's trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of +1.71% per trade.
Copying Emmanuel Papadakis's trades and holding each position for 1 Year would result in 55.88% of your transactions generating a profit, with an average return of +7.98% per trade.
Copying Emmanuel Papadakis's trades and holding each position for 2 Years would result in 44.12% of your transactions generating a profit, with an average return of +11.27% per trade.
NOV Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 0 | 0 | 0 |
| Hold | 27 | 25 | 29 | 27 | 21 |
| Sell | 2 | 2 | 7 | 8 | 9 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 31 | 29 | 36 | 35 | 30 |
In the current month, NOV has received 0 Buy Ratings, 21 Hold Ratings, and 9 Sell Ratings. NOV average Analyst price target in the past 3 months is 38.61.
NOV Financial Forecast
NOV Earnings Forecast
Next quarter’s earnings estimate for NOV is EUR 0.60 with a range of EUR 0.44 to EUR 0.69. The previous quarter’s EPS was EUR 0.77. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
NOV Sales Forecast
Next quarter’s sales forecast for NOV is EUR 10.54B with a range of EUR 9.66B to EUR 11.13B. The previous quarter’s sales results were EUR 10.59B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

